Dear Sir/ Madam, Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find attached the intimation. Kindly take the same ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.5%1-day move

₹26.34

prior close

₹25.81

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+6.8+6.8+6.8+4.6+2.5+2.9+8.2+15.8+13.9+21.5+18.6+19.6+8.6+8.2

Up moveDown movePending

AI summary

Prism Medico and Pharmacy Ltd has filed a compliance intimation under SEBI Regulation 57(5) confirming that the company has not issued any non-convertible securities. Consequently, there were no interest, dividend, or principal payment obligations due during the quarter January 1, 2026 to March 31, 2026. The filing was made to BSE and Metropolitan Stock Exchange of India Limited (MSED) on April 6, 2026. The company is listed on BSE with scrip code 512217 and on MSED. This is a routine regulatory confirmation to disclose that no payment obligations arose in Q4 FY26.

Likely market impact

No direct impact on shareholders or stock price. This is a standard nil-reporting filing confirming that the company had zero non-convertible securities-related payment obligations during the quarter.